Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Murphy

Showing results (741-750 of 751) with videos related to

Pageof 76
Sort By:
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Prostate|February 11, 1999
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic diseaseG P Murphy, B A Tjoa, S J Simmons, et al.
The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.
The Journal of Urology|May 1, 1981
Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostateM S Soloway, J B deKernion, R P Gibbons, et al.
Nature|July 27, 1999
'Green revolution' genes encode mutant gibberellin response modulatorsJ Peng, D E Richards, N M Hartley, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Cancer|March 1, 1982
Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic responseL P Pertschuk, H E Rosenthal, R J Macchia, et al.
The Journal of Urology|January 1, 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral areaM S Soloway, S Beckley, M F Brady, et al.
Cancer|April 1, 1983
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneG P Murphy, S Beckley, M F Brady, et al.
The Journal of Urology|May 1, 1983
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancerS A Loening, S Beckley, M F Brady, et al.
Pageof 76

Showing results (741-750 of 751) with videos related to

Sort By:
Pageof 76
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Prostate|February 11, 1999
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic diseaseG P Murphy, B A Tjoa, S J Simmons, et al.
The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.
The Journal of Urology|May 1, 1981
Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostateM S Soloway, J B deKernion, R P Gibbons, et al.
Nature|July 27, 1999
'Green revolution' genes encode mutant gibberellin response modulatorsJ Peng, D E Richards, N M Hartley, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Cancer|March 1, 1982
Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic responseL P Pertschuk, H E Rosenthal, R J Macchia, et al.
The Journal of Urology|January 1, 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral areaM S Soloway, S Beckley, M F Brady, et al.
Cancer|April 1, 1983
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneG P Murphy, S Beckley, M F Brady, et al.
The Journal of Urology|May 1, 1983
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancerS A Loening, S Beckley, M F Brady, et al.
Pageof 76